← All stocks

NOVAVAX INC

NVAX No buying or selling

CIK 0001000694 #2303 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

15 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Jacobs John C

President and CEO

—

225,680

$1.81M

—

O'Hara Elaine

EVP, Chief Strategy Officer

—

134,642

$1.08M

+846.5%

Kelly James Patrick

EVP, CFO and Treasurer

—

130,599

$1.04M

+671.9%

Casey Mark J

EVP, Chief Legal Officer

—

90,067

$720.54K

—

MOTT DAVID M

Director

—

79,770

$638.16K

+58.1%

DOUGLAS RICHARD

Director

—

73,220

$585.76K

+66.7%

Trizzino John

President and COO

—

68,061

$544.49K

+140.4%

YOUNG JAMES F

Director

—

51,760

$414.08K

−16.2%

Alton Gregg H

Director

—

47,685

$381.48K

+216.0%

Rodgers Richard J

Director

—

47,370

$378.96K

+352.4%

MCGLYNN MARGARET G

Director

—

44,468

$355.74K

+236.6%

King Rachel K.

Director

—

44,070

$352.56K

+132.9%

Draghia-Akli Ruxandra

EVP, Research & Development

—

23,563

$188.50K

—

Newton Charles W.

Director

—

9,520

$76.16K

—

Shiver John W.

Director

—

7,947

$63.58K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 21 Sep 2016